[ Price : $8.95]
Drug Safety Oversight Board executive director Steven Osborne tells reporters that greater transparency in board meeting summaries...[ Price : $8.95]
Federal Register Notice: FDAs Menthol Report Subcommittee will meet 9/27 to discuss the timelines and structure of the report on t...[ Price : $8.95]
FDA says Celsions Phase 3 HEAT study of ThermoDox and radiofrequency ablation in primary liver cancer patients is a fast-track dev...[ Price : $8.95]
FDAs New England District Office warns Albany Molecular Research about CGMP problems at its Burlington, MA, drug manufacturing fac...[ Price : $8.95]
Consumers Union says many Americans who take prescription drugs are concerned that drug companies have too great an influence over...[ Price : $8.95]
FDA gives Prolor Biotech regulatory approval to conduct a Phase 2 clinical trial in the U.S. using its longer-acting version of hu...[ Price : $8.95]
An FDA MedWatch notice advises healthcare providers about a Class 1 recall involving Ikaria's vasodilator Inomax (nitric oxide).[ Price : $8.95]
FDA grants in part and denies in part two citizen petitions on bioequivalence requirements for generic forms of mesalamine product...